docosahexaenoic acids

Preferred Label : docosahexaenoic acids;

MeSH definition : C22-unsaturated fatty acids found predominantly in FISH OILS.;

MeSH synonym : acids, docosahexaenoic; acids, docosahexenoic; docosahexenoic acids; Docosahexaenoic Acid; Acid, Docosahexaenoic;

MeSH hyponym : docosahexaenoic acid dimer (All-Z isomer); docosahexaenoic acid, 3,6,9,12,15,18-Isomer; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer); docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cerium salt; docosahexaenoic acid, 4,7,10,13,16,19-Isomer; docosahexaenoic acid, sodium salt; docosahexaenoic acid (All-Z isomer); Docosahexaenoate; docosahexaenoic acid, 4,7,10,13,16,19-Isomer, sodium salt; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), potassium salt; docosahexaenoic acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer); docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cesium salt;

MeSH Related Number : docosahexaenoic acid, sodium salt; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cesium salt; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), potassium salt; docosahexaenoic acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer); docosahexaenoic acid, 4,7,10,13,16,19-Isomer; docosahexaenoic acid, 4,7,10,13,16,19-Isomer, sodium salt; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cerium salt; docosahexaenoic acid (All-Z isomer); docosahexaenoic acid dimer (All-Z isomer); docosahexaenoic acid, 3,6,9,12,15,18-Isomer; docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer); 121191-40-0; 122045-76-5; 123301-30-4; 123301-31-5; 124020-09-3; 2091-24-9; 32839-18-2; 6217-54-5; 6610-27-1; 89022-31-1; 91403-70-2;

Registry Number MeSH : 25167-62-8;

Related CAS MeSH : 32839-18-2 (Docosahexaenoic acid (All-Z isomer)); 122045-76-5 (Docosahexaenoic acid dimer (All-Z isomer)); 89022-31-1 (Docosahexaenoic acid, 3,6,9,12,15,18-Isomer); 6217-54-5 (Docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer)); 91403-70-2 (Docosahexaenoic acid, sodium salt); 123301-30-4 (Docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cesium salt); 121191-40-0 (Docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), potassium salt); 124020-09-3 (Docosahexaenoic acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)); 2091-24-9 (Docosahexaenoic acid, 4,7,10,13,16,19-Isomer); 6610-27-1 (Docosahexaenoic acid, 4,7,10,13,16,19-Isomer, sodium salt); 123301-31-5 (Docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cerium salt);

Wikipedia link : https://en.wikipedia.org/wiki/Docosahexaenoic acid;

Is substance : O;

Details

Origin ID

D004281;

UMLS CUI

C0012968;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Docosahexaenoic acid supplementation (product) [SNOMED CT concept]
- docosahexaenoic acid [Artificial nutrition thesaurus concept]
Record concept(s)
- Docosahexaenoate [MeSH concept]
- docosahexaenoic acid (All-Z isomer) [MeSH concept]
- docosahexaenoic acid dimer (All-Z isomer) [MeSH concept]
- docosahexaenoic acid, 3,6,9,12,15,18-Isomer [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer) [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cerium salt [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), cesium salt [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-(All-Z-Isomer), potassium salt [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-Isomer [MeSH concept]
- docosahexaenoic acid, 4,7,10,13,16,19-Isomer, sodium salt [MeSH concept]
- docosahexaenoic acid, sodium salt [MeSH concept]
- docosahexaenoic acids [MeSH concept]
Related MeSH Supplementary Concept(s)
- 10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid [MeSH Supplementary Concept]
- 11-hydroxydocosahexaenoic acid [MeSH Supplementary Concept]
- 13,14-dihydroxydocosahexaenoic acid [MeSH Supplementary Concept]
- 14,20-dihydroxy-docosahexaenoic acid [MeSH Supplementary Concept]
- 14,21-dihydroxydocosa-4,7,10,12,16,19-hexaenoic acid [MeSH Supplementary Concept]
- 14-A4t-neuroprostane [MeSH Supplementary Concept]
- 14-hydroxydocosahexaenoic acid [MeSH Supplementary Concept]
- 16S,17S-epoxyprotectin [MeSH Supplementary Concept]
- 17-hydro-(peroxy)-docosahexaenoic acid [MeSH Supplementary Concept]
- 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid [MeSH Supplementary Concept]
- 19,20-epoxydocosapentaenoic acid [MeSH Supplementary Concept]
- 1a-docosahexaenoyl mitomycin C [MeSH Supplementary Concept]
- 2,6-diisopropylphenol docosahexaenoate [MeSH Supplementary Concept]
- 22-OH-PD1 compound [MeSH Supplementary Concept]
- 4(S)-11-dihydroxydocosahexaenoic acid [MeSH Supplementary Concept]
- 4,7,10,13,16,19-docosahexaenoic acid ethyl ester [MeSH Supplementary Concept]
- 4-oxo-5,7,10,13,16,19-docosahexaenoic acid [MeSH Supplementary Concept]
- 6,9,12,15,18,21-tetracosahexaenoic acid [MeSH Supplementary Concept]
- 7(S)-hydroxy-docosahexaenoic acid [MeSH Supplementary Concept]
- 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid [MeSH Supplementary Concept]
- CRBM 0244 [MeSH Supplementary Concept]
- DHA-HCPT conjugate [MeSH Supplementary Concept]
- F 16915 [MeSH Supplementary Concept]
- Fortasyn Connect [MeSH Supplementary Concept]
- Maxepa [MeSH Supplementary Concept]
- N-(2,6-diisopropylphenyl)-4,7,10,13,16,19-docosahexaenamide [MeSH Supplementary Concept]
- N-docosahexaenoyl vanillylamine [MeSH Supplementary Concept]
- N-docosahexaenoylethanolamide [MeSH Supplementary Concept]
- N-docosahexaenoylserine phosphate [MeSH Supplementary Concept]
- N-docosahexaenoylthreonine phosphate [MeSH Supplementary Concept]
- N-docosahexaenoyltyrosine phosphate [MeSH Supplementary Concept]
- NMI 8739 [MeSH Supplementary Concept]
- Omacor [MeSH Supplementary Concept]
- TAK-085 [MeSH Supplementary Concept]
- TH-DPA [MeSH Supplementary Concept]
- TP-113 [MeSH Supplementary Concept]
- angiosan [MeSH Supplementary Concept]
- chlorambucil-docosahexaenoic acid conjugate [MeSH Supplementary Concept]
- diHEP-DPA [MeSH Supplementary Concept]
- docanol [MeSH Supplementary Concept]
- docosahexaenoic acid hydroperoxide [MeSH Supplementary Concept]
- docosahexaenoyl lysophosphatidylcholine [MeSH Supplementary Concept]
- docosahexaenoylascorbic acid [MeSH Supplementary Concept]
- docosahexaenoylnoylphosphatidate [MeSH Supplementary Concept]
- methyl docosahexaenoate [MeSH Supplementary Concept]
- protectin D1 [MeSH Supplementary Concept]
- purepa [MeSH Supplementary Concept]
- resolvin D1 [MeSH Supplementary Concept]
- resolvin D2 [MeSH Supplementary Concept]
- resolvin D5 [MeSH Supplementary Concept]
- tetracosahexaenoic acid [MeSH Supplementary Concept]
- tetracosapentaenoic acid [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- fish oils [MeSH Descriptor]
See also inter- (CISMeF)
- Docosahexaenoate (C22:6w3) [LOINC component]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients